Aurinia Pharmaceuticals (AUPH) rockets on good news
What’s up with Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals (AUPH) opened at $16.28, which means the stock is up 9.41% from yesterday’s closing price of 16.15. Today, the company has a high of $17.98 and a low of $15.95. The company has a market cap of $1.96 billion with a 52-week high of $21.93 and a 52-week low of $3.52.
What about the future forAurinia Pharmaceuticals
The high forecast for Aurinia Pharmaceuticals is 32.00 while the low is 20.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. Aurinia Pharmaceuticals has a strong forecast. A strong forecast is a result of strong earning reports as investors are willing to pay a higher share price today because of growth expectations in the future.. Based on this information AUPH seems to be a safe buy.
About Aurinia Pharmaceuticals
Aurinia is a late clinical-stage biopharmaceutical company focused on developing and commercializing therapies to change the treatment paradigm for patients impacted by rare autoimmune and inflammatory conditions.